Wasatch Advisors Inc

SEC CIK: 0000814133
Latest filing: Jul 9, 2026

SEC filings (opens in a new tab)

NRIX holding history

Nurix Therapeutics, Inc. in every 13F filed by Wasatch Advisors Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NRIX overview All 13F holders of NRIX Full Q2 2026 holdings

Shares (Q4 2025): 0; Sold out in Q4 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 19; Since Q1 2021

Holdings of NRIX by Wasatch Advisors Inc, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2025	0	$0	0.0%	−313,889−100.0%	Sold out	Holders
Q3 2025	313,889	$2.90M	<0.1%	−173,047−35.5%	Reduced	Holders
Q2 2025	486,936	$5.55M	<0.1%	−82,861−14.5%	Reduced	Holders
Q1 2025	569,797	$6.77M	<0.1%	−29,604−4.9%	Reduced	Holders
Q4 2024	599,401	$11.3M	0.1%	−108,976−15.4%	Reduced	Holders
Q3 2024	708,377	$15.9M	0.1%	−149,690−17.4%	Reduced	Holders
Q2 2024	858,067	$17.9M	0.1%	−378,686−30.6%	Reduced	Holders
Q1 2024	1,236,753	$18.2M	0.1%	−1,512,992−55.0%	Reduced	Holders
Q4 2023	2,749,745	$28.4M	0.2%	−814,871−22.9%	Reduced	Holders
Q3 2023	3,564,616	$28.0M	0.2%	−305,159−7.9%	Reduced	Holders
Q2 2023	3,869,775	$38.7M	0.2%	+695,773+21.9%	Added	Holders
Q1 2023	3,174,002	$28.2M	0.2%	+635,370+25.0%	Added	Holders
Q4 2022	2,538,632	$27.9M	0.2%	−118,805−4.5%	Reduced	Holders
Q3 2022	2,657,437	$34.6M	0.2%	+394,374+17.4%	Added	Holders
Q2 2022	2,263,063	$28.7M	0.2%	+716,374+46.3%	Added	Holders
Q1 2022	1,546,689	$21.7M	0.1%	+343,100+28.5%	Added	Holders
Q4 2021	1,203,589	$34.8M	0.1%	+31,932+2.7%	Added	Holders
Q3 2021	1,171,657	$35.1M	0.1%	−22,958−1.9%	Reduced	Holders
Q2 2021	1,194,615	$31.7M	0.1%	+158,914+15.3%	Added	Holders
Q1 2021	1,035,701	$32.2M	0.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.